Companies › EDSA

EDESA BIOTECH INC COM NEW (EDSA)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001540159 · EDGAR filings · Updated 2026-07-13

EDESA BIOTECH INC COM NEW (EDSA) has reported institutional ownership of 29.7%, with 28 institutional managers holding positions valued at $13.8M per the latest 13F reporting period. SEC filings include an active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.

Latest updates

• 2026-07-13 — EFFECT filed
• 2026-07-13 — Prospectus supplement (424B3) filed
• 2026-07-02 — Insider transaction reported (Form 4)
• 2026-07-02 — Shelf registration (S-3) filed
• 2026-06-26 — D filed
• 2026-06-18 — SCHEDULE 13G filed

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, EDESA BIOTECH INC COM NEW has 28 institutional holders and institutional ownership of 29.7%.

Insider activity

Insiders reported 31 transactions (9 buys, 0 sells) across 9 reporting insiders, with a net reported value of $233.0K.

Data flags from SEC filings

Related companies

QT IMAGING HLDGS INC (QTI) · Jasper Therapeutics Inc (JSPR) · PASSAGE BIO INC COM NEW (PASG) · POLYPID LTD (PYPD) · PALATIN TECHNOLOGIES INC (PTN) · Alpha Pro Tech Ltd (APT)